ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!
Search for

UniProtKB/Swiss-Prot entry P17948


[Entry info] [Name and origin] [References] [Comments] [Cross-references] [Keywords] [Features] [Sequence] [Tools]

Note: most headings are clickable, even if they don't appear as links. They link to the user manual or other documents.
Entry information
Entry name VGFR1_HUMAN
Primary accession number P17948
Secondary accession numbers O60722 P16057 Q12954
Integrated into Swiss-Prot on November 1, 1990
Sequence was last modified on April 3, 2007 (Sequence version 2)
Annotations were last modified on    June 16, 2009 (Entry version 120)
Name and origin of the protein
Protein name Vascular endothelial growth factor receptor 1 [Precursor]
Synonyms VEGFR-1
EC 2.7.10.1
Vascular permeability factor receptor
Tyrosine-protein kinase receptor FLT
Flt-1
Tyrosine-protein kinase FRT
Fms-like tyrosine kinase 1
Gene name
Name: FLT1
Synonyms: FLT, FRT
From
Homo sapiens (Human) [TaxID: 9606] 
Taxonomy Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo.
Protein existence 1: Evidence at protein level;
References
[1]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM FLT1).
TISSUE=Placenta;
PubMed=2158038 [NCBI, ExPASy, EBI, Israel, Japan]
Shibuya M., Yamaguchi S., Yamane A., Ikeda T., Tojo A., Matsushime H., Sato M.;
"Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family.";
Oncogene 5:519-524(1990).
[2]
NUCLEOTIDE SEQUENCE (ISOFORM FLT1).
TISSUE=Umbilical vein;
Yu Y., Whitney R.G., Sato J.D.;
"Coding region for human VEGF receptor FLT1 (VEGFR-1).";
Submitted (MAY-1998) to the EMBL/GenBank/DDBJ databases.
[3]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SFLT1), AND PROTEIN SEQUENCE OF N-TERMINUS.
TISSUE=Umbilical vein;
DOI=10.1073/pnas.90.22.10705; PubMed=8248162 [NCBI, ExPASy, EBI, Israel, Japan]
Kendall R.L., Thomas K.A.;
"Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.";
Proc. Natl. Acad. Sci. U.S.A. 90:10705-10709(1993).
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM SFLT1).
TISSUE=Ovary;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[5]
NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1018-1058 (ISOFORM FLT1).
PubMed=3040650 [NCBI, ExPASy, EBI, Israel, Japan]
Matsushime H., Yoshida M.C., Sasaki M., Shibuya M.;
"A possible new member of tyrosine kinase family, human frt sequence, is highly conserved in vertebrates and located on human chromosome 13.";
Jpn. J. Cancer Res. 78:655-661(1987).
[6]
PARTIAL PROTEIN SEQUENCE, PHOSPHORYLATION AT TYR-1213; TYR-1242; TYR-1327 AND TYR-1333, AND MUTAGENESIS OF TYR-914; TYR-1213; TYR-1242; TYR-1327 AND TYR-1333.
DOI=10.1074/jbc.273.36.23410; PubMed=9722576 [NCBI, ExPASy, EBI, Israel, Japan]
Ito N., Wernstedt C., Engstrom U., Claesson-Welsh L.;
"Identification of vascular endothelial growth factor receptor-1 tyrosine phosphorylation sites and binding of SH2 domain-containing molecules.";
J. Biol. Chem. 273:23410-23418(1998).
[7]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-1048 AND TYR-1053, AND MASS SPECTROMETRY.
DOI=10.1016/j.cell.2007.11.025; PubMed=18083107 [NCBI, ExPASy, EBI, Israel, Japan]
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J., Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L., Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J., Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X., Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
"Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer.";
Cell 131:1190-1203(2007).
[8]
STRUCTURE BY NMR OF 129-229.
DOI=10.1006/jmbi.1999.3134; PubMed=10543948 [NCBI, ExPASy, EBI, Israel, Japan]
Starovasnik M.A., Christinger H.W., Wiesmann C., Champe M.A., de Vos A.M., Skelton N.J.;
"Solution structure of the VEGF-binding domain of Flt-1: comparison of its free and bound states.";
J. Mol. Biol. 293:531-544(1999).
[9]
VARIANTS [LARGE SCALE ANALYSIS] THR-60; LYS-144; GLN-281; ILE-422; GLN-781; VAL-938; ALA-982 AND VAL-1061.
DOI=10.1038/nature05610; PubMed=17344846 [NCBI, ExPASy, EBI, Israel, Japan]
Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
"Patterns of somatic mutation in human cancer genomes.";
Nature 446:153-158(2007).
Comments
Copyright
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms. Distributed under the Creative Commons Attribution-NoDerivs License.
Cross-references
Sequence databases
EMBL
X51602; CAA35946.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AF063657; AAC16449.2; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U01134; AAC50060.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
BC039007; AAH39007.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
D00133; BAA00080.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
IPI IPI00018335; -.
IPI00216043; -.
PIR A49636; A49636.
S09982; S09982.
RefSeq NP_002010.2; -.
UniGene Hs.654360
3D structure databases
PDB
1FLT; X-ray; 1.70 A; X/Y=132-226.[ExPASy / RCSB / EBI]
1QSV; NMR; -; A=129-229.[ExPASy / RCSB / EBI]
1QSZ; NMR; -; A=129-229.[ExPASy / RCSB / EBI]
1QTY; X-ray; 2.70 A; T/U/X/Y=129-229.[ExPASy / RCSB / EBI]
1RV6; X-ray; 2.45 A; X/Y=130-229.[ExPASy / RCSB / EBI]
Detailed list of linked structures.
PDBsum 1FLT; -.
1QSV; -.
1QSZ; -.
1QTY; -.
1RV6; -.
ModBase P17948.
Protein-protein interaction databases
DIP DIP:643N; -.
PTM databases
PhosphoSite P17948; -.
Enzyme and pathway databases
BRENDA 2.7.10.1; 247.
Pathway_Interaction_DB glypican_1pathway; Glypican 1 network.
s1p_s1p3_pathway; S1P3 pathway.
vegfr1_2_pathway; Signaling events mediated by VEGFR1 and VEGFR2.
vegfr1_pathway; VEGFR1 specific signals.
Reactome REACT_12529; Signaling by VEGF.
Organism-specific databases
GeneCards GC13M027773; -.
H-InvDB HIX0026543; -.
HIX0037569; -.
HGNC HGNC:3763; FLT1.
GenAtlas FLT1.
MIM 165070; gene. [NCBI / EBI]
PharmGKB PA28180; -.
Gene expression databases
ArrayExpress P17948; -.
Bgee P17948; -.
CleanEx HS_FLT1; -.
GermOnline ENSG00000102755; Homo sapiens.
Ontologies
GO
GO:0005615; Cellular component: extracellular space (traceable author statement from ProtInc).
GO:0005887; Cellular component: integral to plasma membrane (traceable author statement from ProtInc).
GO:0005524; Molecular function: ATP binding (inferred from electronic annotation from UniProtKB-KW).
GO:0019838; Molecular function: growth factor binding (inferred from physical interaction from UniProtKB).
GO:0005021; Molecular function: vascular endothelial growth factor receptor activity (inferred from direct assay from UniProtKB).
GO:0030154; Biological process: cell differentiation (inferred from electronic annotation from UniProtKB-KW).
GO:0007565; Biological process: female pregnancy (traceable author statement from ProtInc).
GO:0008284; Biological process: positive regulation of cell proliferation (traceable author statement from ProtInc).
GO:0030949; Biological process: positive regulation of vascular endothelial growth factor receptor signaling pathway (inferred from direct assay from UniProtKB).
GO:0006468; Biological process: protein amino acid phosphorylation (inferred from electronic annotation from InterPro).
GO:0007169; Biological process: transmembrane receptor protein tyrosine kinase signaling pathway (traceable author statement from ProtInc).
QuickGo view.
Family and domain databases
InterPro IPR013151; Ig.
IPR007110; Ig-like.
IPR013783; Ig-like_fold.
IPR013098; Ig_I-set.
IPR003599; Ig_sub.
IPR003598; Ig_sub2.
IPR000719; Prot_kinase_core.
IPR017441; Protein_kinase_ATP_BS.
IPR001824; Recept_tyr_kinase-III_CS.
IPR001245; Tyr_pkinase.
IPR008266; Tyr_pkinase_AS.
IPR009135; VEGFR1_N.
IPR009134; VEGFR_N.
Graphical view of domain structure.
Gene3D G3DSA:2.60.40.10; Ig-like_fold; 6.
Pfam PF07679; I-set; 2.
PF00047; ig; 2.
PF07714; Pkinase_Tyr; 1.
Pfam graphical view of domain structure.
PRINTS PR01832; VEGFRECEPTOR.
PR01833; VEGFRECEPTR1.
ProDom PD000001; Prot_kinase; 2.
[Domain structure / List of seq. sharing at least 1 domain]
SMART SM00409; IG; 5.
SM00408; IGc2; 2.
SM00219; TyrKc; 1.
SMART graphical view of domain structure.
PROSITE PS50835; IG_LIKE; 6.
PS00107; PROTEIN_KINASE_ATP; 1.
PS50011; PROTEIN_KINASE_DOM; 1.
PS00109; PROTEIN_KINASE_TYR; 1.
PS00240; RECEPTOR_TYR_KIN_III; 1.
PROSITE graphical view of domain structure (profiles).
Proteomic databases
PRIDE P17948; -.
Genome annotation databases
Ensembl ENSG00000102755; Homo sapiens. [Contig view]
GeneID 2321; -.
KEGG hsa:2321; -.
Phylogenomic databases
HOGENOM P17948; -.
HOVERGEN P17948; -.
OMA P17948; DYNSVVL.
Other
DrugBank DB01268; Sunitinib.
NextBio 9421; -.
SOURCE FLT1; Homo sapiens.
ProtoNet P17948.
UniRef View cluster of proteins with at least 50% / 90% / 100% identity.
Keywords
3D-structure; Alternative splicing; Angiogenesis; ATP-binding; Cell membrane; Developmental protein; Differentiation; Direct protein sequencing; Disulfide bond; Glycoprotein; Immunoglobulin domain; Kinase; Membrane; Nucleotide-binding; Phosphoprotein; Polymorphism; Receptor; Repeat; Secreted; Signal; Transferase; Transmembrane; Tyrosine-protein kinase.
Features
SEVIEWER logo Feature table viewer FT aligner logo Feature aligner
KeyFrom    To Length Description FTId
SIGNAL   1     26  26      
CHAIN   27   1338  1312     Vascular endothelial growth factor receptor 1. PRO_0000016768
TOPO_DOM   27    758  732     Extracellular (Potential). 
TRANSMEM   759    780  22     Potential. 
TOPO_DOM   781   1338  558     Cytoplasmic (Potential). 
DOMAIN   32    123  92     Ig-like C2-type 1. 
DOMAIN   151    214  64     Ig-like C2-type 2. 
DOMAIN   230    327  98     Ig-like C2-type 3. 
DOMAIN   335    421  87     Ig-like C2-type 4. 
DOMAIN   428    553  126     Ig-like C2-type 5. 
DOMAIN   556    654  99     Ig-like C2-type 6. 
DOMAIN   661    747  87     Ig-like C2-type 7. 
DOMAIN   827   1158  332     Protein kinase. 
NP_BIND   833    841  9     ATP (By similarity). 
ACT_SITE   1022   1022        Proton acceptor (By similarity). 
BINDING   861    861        ATP (By similarity). 
MOD_RES   1048   1048        Phosphotyrosine. 
MOD_RES   1053   1053        Phosphotyrosine; by autocatalysis (By similarity). 
MOD_RES   1169   1169        Phosphotyrosine; by autocatalysis (By similarity). 
MOD_RES   1213   1213        Phosphotyrosine; by autocatalysis. 
MOD_RES   1242   1242        Phosphotyrosine; by autocatalysis. 
MOD_RES   1327   1327        Phosphotyrosine; by autocatalysis. 
MOD_RES   1333   1333        Phosphotyrosine; by autocatalysis. 
CARBOHYD   100    100        N-linked (GlcNAc...) (Potential). 
CARBOHYD   164    164        N-linked (GlcNAc...) (Potential). 
CARBOHYD   196    196        N-linked (GlcNAc...) (Potential). 
CARBOHYD   251    251        N-linked (GlcNAc...) (Potential). 
CARBOHYD   323    323        N-linked (GlcNAc...) (Potential). 
CARBOHYD   402    402        N-linked (GlcNAc...) (Potential). 
CARBOHYD   417    417        N-linked (GlcNAc...) (Potential). 
CARBOHYD   474    474        N-linked (GlcNAc...) (Potential). 
CARBOHYD   547    547        N-linked (GlcNAc...) (Potential). 
CARBOHYD   597    597        N-linked (GlcNAc...) (Potential). 
CARBOHYD   620    620        N-linked (GlcNAc...) (Potential). 
CARBOHYD   625    625        N-linked (GlcNAc...) (Potential). 
CARBOHYD   666    666        N-linked (GlcNAc...) (Potential). 
DISULFID   53    107        Potential. 
DISULFID   158    207         
DISULFID   252    311        Potential. 
DISULFID   454    535        Potential. 
DISULFID   577    636        Potential. 
DISULFID   682    731        Potential. 
VAR_SEQ   657    687        DQEAPYLLRNLSDHTVAISSSTTLDCHANGV -> GEHCNKKAVFSRISKFKSTRNDCTTQSNVKH (in isoform sFlt1). VSP_002955
VAR_SEQ   688   1338        Missing (in isoform sFlt1). VSP_002956
VARIANT   60     60  1     K -> T. VAR_042045 
VARIANT   128    128  1     I -> L (in dbSNP:rs35073261 [NCBI]). VAR_049719 
VARIANT   144    144  1     E -> K. VAR_042046 [3D]
VARIANT   281    281  1     R -> Q. VAR_042047 
VARIANT   422    422  1     L -> I (in a lung adenocarcinoma sample; somatic mutation). VAR_042048 
VARIANT   781    781  1     R -> Q (in a glioma low grade oligodendroglioma sample; somatic mutation). VAR_042049 
VARIANT   938    938  1     M -> V. VAR_042050 
VARIANT   982    982  1     E -> A (in dbSNP:rs35832528 [NCBI]). VAR_042051 
VARIANT   1061   1061  1     L -> V (in a bladder transitional cell carcinoma sample; somatic mutation). VAR_042052 
MUTAGEN   914    914        Y->F: No loss of phosphorylation. 
MUTAGEN   1213   1213        Y->F: Loss of phosphorylation. 
MUTAGEN   1242   1242        Y->F: Loss of phosphorylation. 
MUTAGEN   1327   1327        Y->F: Loss of phosphorylation. 
MUTAGEN   1333   1333        Y->F: Loss of phosphorylation. 
CONFLICT   490    490        F -> S (in Ref. 2; AAC16449). 
CONFLICT   779    779        F -> L (in Ref. 1; CAA35946). 
STRAND   135    137  3      
STRAND   144    148  5      
STRAND   154    156  3      
STRAND   168    171  4      
TURN   172    174  3      
STRAND   175    177  3      
STRAND   181    187  7      
TURN   188    190  3      
STRAND   191    196  6      
HELIX   199    201  3      
STRAND   203    211  9      
STRAND   214    224  11      
Sequence information
Length: 1338 AA [This is the length of the unprocessed precursor] Molecular weight: 150769 Da [This is the MW of the unprocessed precursor] CRC64: FF3381EEFAF0787C [This is a checksum on the sequence]
        10         20         30         40         50         60 
MVSYWDTGVL LCALLSCLLL TGSSSGSKLK DPELSLKGTQ HIMQAGQTLH LQCRGEAAHK 

        70         80         90        100        110        120 
WSLPEMVSKE SERLSITKSA CGRNGKQFCS TLTLNTAQAN HTGFYSCKYL AVPTSKKKET 

       130        140        150        160        170        180 
ESAIYIFISD TGRPFVEMYS EIPEIIHMTE GRELVIPCRV TSPNITVTLK KFPLDTLIPD 

       190        200        210        220        230        240 
GKRIIWDSRK GFIISNATYK EIGLLTCEAT VNGHLYKTNY LTHRQTNTII DVQISTPRPV 

       250        260        270        280        290        300 
KLLRGHTLVL NCTATTPLNT RVQMTWSYPD EKNKRASVRR RIDQSNSHAN IFYSVLTIDK 

       310        320        330        340        350        360 
MQNKDKGLYT CRVRSGPSFK SVNTSVHIYD KAFITVKHRK QQVLETVAGK RSYRLSMKVK 

       370        380        390        400        410        420 
AFPSPEVVWL KDGLPATEKS ARYLTRGYSL IIKDVTEEDA GNYTILLSIK QSNVFKNLTA 

       430        440        450        460        470        480 
TLIVNVKPQI YEKAVSSFPD PALYPLGSRQ ILTCTAYGIP QPTIKWFWHP CNHNHSEARC 

       490        500        510        520        530        540 
DFCSNNEESF ILDADSNMGN RIESITQRMA IIEGKNKMAS TLVVADSRIS GIYICIASNK 

       550        560        570        580        590        600 
VGTVGRNISF YITDVPNGFH VNLEKMPTEG EDLKLSCTVN KFLYRDVTWI LLRTVNNRTM 

       610        620        630        640        650        660 
HYSISKQKMA ITKEHSITLN LTIMNVSLQD SGTYACRARN VYTGEEILQK KEITIRDQEA 

       670        680        690        700        710        720 
PYLLRNLSDH TVAISSSTTL DCHANGVPEP QITWFKNNHK IQQEPGIILG PGSSTLFIER 

       730        740        750        760        770        780 
VTEEDEGVYH CKATNQKGSV ESSAYLTVQG TSDKSNLELI TLTCTCVAAT LFWLLLTLFI 

       790        800        810        820        830        840 
RKMKRSSSEI KTDYLSIIMD PDEVPLDEQC ERLPYDASKW EFARERLKLG KSLGRGAFGK 

       850        860        870        880        890        900 
VVQASAFGIK KSPTCRTVAV KMLKEGATAS EYKALMTELK ILTHIGHHLN VVNLLGACTK 

       910        920        930        940        950        960 
QGGPLMVIVE YCKYGNLSNY LKSKRDLFFL NKDAALHMEP KKEKMEPGLE QGKKPRLDSV 

       970        980        990       1000       1010       1020 
TSSESFASSG FQEDKSLSDV EEEEDSDGFY KEPITMEDLI SYSFQVARGM EFLSSRKCIH 

      1030       1040       1050       1060       1070       1080 
RDLAARNILL SENNVVKICD FGLARDIYKN PDYVRKGDTR LPLKWMAPES IFDKIYSTKS 

      1090       1100       1110       1120       1130       1140 
DVWSYGVLLW EIFSLGGSPY PGVQMDEDFC SRLREGMRMR APEYSTPEIY QIMLDCWHRD 

      1150       1160       1170       1180       1190       1200 
PKERPRFAEL VEKLGDLLQA NVQQDGKDYI PINAILTGNS GFTYSTPAFS EDFFKESISA 

      1210       1220       1230       1240       1250       1260 
PKFNSGSSDD VRYVNAFKFM SLERIKTFEE LLPNATSMFD DYQGDSSTLL ASPMLKRFTW 

      1270       1280       1290       1300       1310       1320 
TDSKPKASLK IDLRVTSKSK ESGLSDVSRP SFCHSSCGHV SEGKRRFTYD HAELERKIAC 

      1330 
CSPPPDYNSV VLYSTPPI 

P17948 in FASTA format

View entry in raw text format (no links)
Report form for errors/updates in this UniProtKB/Swiss-Prot entry

BLAST logo BLAST submission on ExPASy/SIB
or at NCBI (USA)
Tools Sequence analysis tools: ProtParam, ProtScale, Compute pI/Mw, PeptideMass, PeptideCutter, Dotlet (Java)
PROSITE logo ScanProsite, MotifScan SWISS-MODEL Submit a homology modeling request to SWISS-MODEL
NPSA logo NPSA Sequence analysis tools

ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
 Hosted by ch flag SIB Switzerland Mirror sites: Australia  Brazil  Canada  China  Korea
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!